SCHEMBL5674161

SCHEMBL5674161

CC(C)C1CNc2ccc(-c3ccc(C(F)(F)F)cc3)nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 11/20 0.40
CHRNA7 P36544 1/20 0.36
FLT3 P36888 1/20 0.35
SYK P43405 1/20 0.35
AURKB Q96GD4 1/20 0.35
KDM1A O60341 1/20 0.35
MAOB P27338 1/20 0.35
KIF11 P52732 1/20 0.35
NISCH Q9Y2I1 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13906449 0.67 MCHR1 (0.41) TRPV3CHRNA7KDM1AMAOBGAA
SCHEMBL1396407 0.67 KIF11 (0.38) TRPV3KDM1AMAOBKIF11NISCH
SCHEMBL6123983 0.65 PARP1 (0.42) TRPV3KDM1AMAOBKIF11NISCH
SCHEMBL6124019 0.65 PGR (0.36) TRPV3KDM1AMAOBKIF11NISCH
SCHEMBL11826597 0.64 NISCH (0.50) KIF11NISCHKDM4ENPC1POLB
SCHEMBL12603819 0.64 MCHR1 (0.43) TRPV3CHRNA7GAA
SCHEMBL2609383 0.63 TRPV3 (0.51) TRPV3KIF11POLB
SCHEMBL29893246 0.63 CYP11B1 (0.50) TRPV3CHRNA7KDM1AMAOBATM
SCHEMBL2609329 0.61 SCN9A (0.56) TRPV3KIF11
SCHEMBL1396656 0.61 KIF11 (0.58) KIF11NPC1POLBRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060100230-A1 Indolin phenylsulfonamide derivatives BAYER HEALTHCARE AG (DE) 2006-05-11 US disclosed
CN-1678581-A Indolin phenylsulfonamide derivatives BAYER HEALTHCARE AG (DE) 2005-10-05 CN disclosed
EP-1519919-A1 INDOLIN PHENYLSULFONAMIDE DERIVATIVES Bayer HealthCare AG (DE) 2005-04-06 EP disclosed
WO-2004005253-A1 INDOLIN PHENYLSULFONAMIDE DERIVATIVES BAYER HEALTHCARE AG (DE) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100230-A1 Indolin phenylsulfonamide derivatives PPARD, PPARA, PPARG TRPV3 647/4885CHRNA7 1376/4885FLT3 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.